Cue Biopharma Reports First Quarter 2023 Financial Results and Recent Business Highlights
BOSTON, May 09, 2023 -- Cue Biopharma, Inc. , a clinical-stage biopharmaceutical company developing a novel class of injectable biologics to selectively engage and modulate disease-specific T... | May 9, 2023
Source: marketscreener.com